Files

703978.pdf (493.01 KB)

Document type

Article

Version

Accepted version

Publication date

2021-05-04

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/178242

Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018)

Journal Title

Authors

Director/Tutor

Additional contribution

Journal ISSN

Volume Title

Abstract

Intrahepatic cholangiocarcinomas (iCCA) are aggressive tumors, often diagnosed in advanced stages and with limited curative treatment options. Their incidence has raised in the past years, increasing their associated economic burden. This study aimed to measure hospital incidence and mortality of iCCA and to evaluate direct medical costs.

Related resource

https://doi.org/10.1080/14737167.2021.1842201

Subject

Cost de l'assistència sanitària, Gestió hospitalària, Hepatitis, Malalties del fetge

Subject (English)

Cost of medical care, Hospital administration, Hepatitis, Liver diseases

Citation

Collections

Articles publicats en revistes (Economia)

Citation

DARBÀ, Josep and MARSÀ, Alícia. Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018). Expert Review of Pharmacoeconomics & Outcomes Research. 2021. Vol. 21, num. 3, pags. 425-431. ISSN 1473-7167. [consulted: 14 of October of 2026]. Available at: https://hdl.handle.net/2445/178242

Export metadata

JSON - METS

Share record